Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Assets Average (2016 - 2023)

Rapid Therapeutic Science Laboratories' Assets Average history spans 8 years, with the latest figure at $2.1 million for Q2 2023.

  • For Q2 2023, Assets Average fell 19.77% year-over-year to $2.1 million; the TTM value through Jun 2023 reached $2.1 million, down 19.77%, while the annual FY2022 figure was $2.2 million, 19.97% up from the prior year.
  • Assets Average for Q2 2023 was $2.1 million at Rapid Therapeutic Science Laboratories, down from $2.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $2.6 million in Q2 2022 and bottomed at $1900.0 in Q2 2019.
  • The 5-year median for Assets Average is $1.2 million (2020), against an average of $1.3 million.
  • The largest annual shift saw Assets Average plummeted 87.72% in 2019 before it skyrocketed 25263.95% in 2020.
  • A 5-year view of Assets Average shows it stood at $227946.0 in 2019, then skyrocketed by 407.75% to $1.2 million in 2020, then skyrocketed by 82.67% to $2.1 million in 2021, then rose by 7.39% to $2.3 million in 2022, then dropped by 9.51% to $2.1 million in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Assets Average are $2.1 million (Q2 2023), $2.1 million (Q1 2023), and $2.3 million (Q4 2022).